Within the Life Sciences industry, research and data are invaluable to productively maintaining the production, risks and operational aspects of your business to remain fiscally balanced and structurally sound.
Toward that goal, we are continually updating our resource materials and educational offerings. Here are some materials relative to Life Sciences situations, insurance and risk liabilities – as well as related organizations that might be useful to you and your teams.
Contract Manufacturing Considerations for the Pharmaceutical Industry [ Whitepaper]
The Life Sciences industry is highly regulated and requires strong partnerships to successfully bring a product to market. As a company prepares for the approval of the FDA planning of its’ commercial supply chains will likely involve a review of the critical Contract Manufacturing Organizations (CMOs).
A New Cyber Alarm for Life Sciences Companies? [ Whitepaper]
Life sciences companies, previously considered low-value cyberattack targets because they often don’t have much easily monetized PII or PHI, avoided much of the early negative cyber publicity. That may change with the SEC’s February 2018 interpretive guidance to public companies’ cybersecurity disclosure obligations.
Latest Hacks Highlight Shortcomings in Cyber Practices in Big Pharma [ Whitepaper]
Biotech and pharmaceutical companies hold sensitive data and information that are crucial to their businesses and that are vulnerable to attack and theft through cybercrime. As cyber risk continues to evolve, expertise is vital. Download the whitepaper below to find out more.
Medical Device Cybersecurity [ Whitepaper]
The world of cyber risk continues to develop and expand since our May 2016 paper on Medical Device Cybersecurity. The threat of ransomware has come to the forefront as demonstrated by global attacks such as Wannacry2 and Petya. These attacks show how hackers have become more sophisticated in their ability to use malware to exploit vulnerabilities in systems, hardware and devices, as well as highlighting the vulnerabilities of devices and systems that, through their lack of patching and support, and outdated operating systems, are exposed to hacking, worms, etc., that can affect patient safety, system security and data integrity.
Synthetic Biology: The Future is Now [ Whitepaper]
Biotechnology and specifically Synthetic Biology (SynBio) is evolving at lightning speed. SynBio makes it possible to engineer life from the ground up (allowing the formation of organisms with genetic code (DNA) not found in the natural world) and to re-design existing natural bio systems for life-changing purposes. The opportunities are limitless and so are the risks.
Life Sciences Services [ Article]
Gallagher life sciences will leverage the marketplace on your behalf to help protect your company’s bottom line from the financial devastation that could result from a loss or lawsuit. Our team of experts will work with you to customize risk management and insurance solution programs that meet your unique needs and protect your organization under the best possible terms and conditions.
2015 Updated - Gallagher Higher Education Think Tank Study: Infectious Disease Emergency Protocol for Colleges and Universities [ Whitepaper]
Even in a modern world of advanced health care, it is distressingly easy to encounter infectious disease conditions that might present a college or university campus with challenges including recently reported U.S. cases of Ebola and measles. For these reasons among others, we felt it was time to update and re-release our 2006 Gallagher Higher Education Think Tank Study - Blueprint for Pandemic Flu with new information.
Ebola: Preparation Continues to be Key [ Article]
Healthcare leaders and organizations around the country continue to closely monitor recommendations from the (Centers for Disease Control) CDC and actively plan training programs in response to the Ebola threat. An important step in this process is to ensure healthcare teams are actively managing and maintaining the resources and systems we have designed into our facilities to manage these risks. This paper will offer recommendations for such considerations.
Risk Management Safety Insight - Ebola and Employer Liability Issues [ Risk Management Safety Newsletter]
There are many risks and liabilities being evaluated with the reporting and spread of the Ebola hemorrhagic virus (EHV) - also known as the Ebola Virus Disease (EVD) World health organization, the media and other federal government entities are aggressively working to find more answers and possible solutions. The United States has only had several cases of the virus, but that hasn't prevented many medical officials from raising concerns about when or if the disease surfaces in more cases and populated common areas in the U.S. How does this issue possibly this impact employers?
Healthcare: The Financial Impact of a Data Breach [ Whitepaper]
Re-Release: As healthcare organizations become increasingly exposed to risks from data security breaches involving protected health information (PHI) or personally identifiable information (PII), it is important to understand the risks and their origin.
The Risk of Duplicate Patient Records [ Whitepaper]
An issue of growing concern for hospitals and healthcare providers is duplicate patient records within their Master Patient Index (MPI). This situation increases the risks of poor patient outcomes and medical malpractice liability.
A Minute for Safety: Chemical Cross-Contamination Risks [ Minute For Safety Newsletter]
Cross-contamination occurs when workers spread contaminants around the worksite and into their homes through soiled clothing, shoes or skin contact. However, if a worker does not properly wash, remove or decontaminate soiled personal protective equipment (PPE) after work, they can spread the contaminants further when they leave.
Workers Compensation: Fall 2013 State of the Market [ Whitepaper]
Despite improvement in insurer underwriting results in 2012, the workers compensation market continues to be challenging to both employers and insurance carriers alike. To gain a broader sense of this situation, review the Gallagher Workers Compensation — Fall 2013 State of the Market whitepaper.
Below is a list of websites that might offer valuable information to your Life Sciences organization:
- U.S. Food & Drug Administration (FDA)
- World Health Organization (WHO)
- European Directorate for the Quality of Medicines and Healthcare (EDQM)
- European Medicines Agency (EMA)
- BioWorld (Worldwide Biotechnology News and Information Source)
- Association of Clinical Research Organizations (ACRO)
- Medical Device Manufacturers Association (MDMA)
- Biotechnology Industry Organization (BIO)
- Council for Entrepreneurial Development (CED)
- Southeastern Medical Device Association (SEMDA)
- Georgia Centers of Innovation for Life Sciences
- Centers for Disease Control (CDC)